Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
hepatitis C
MedTech
FDA unlocks faster clearances for future hepatitis C diagnostics
The reclassification allows diagnostic developers to seek 510(k) clearances instead of completing full premarket approval applications.
Conor Hale
Nov 22, 2021 11:21am
Gilead's virology lead Brainard jumps ship to AlloVir
Mar 23, 2021 7:25am
Ascletis poaches top MSD China exec as its new R&D chief
Mar 1, 2019 9:53am
Ascletis files for Hong Kong IPO
May 8, 2018 9:19am
Bleeding cash, Achillion to cut 20% of workforce
Feb 22, 2018 11:05am
New research on T cells could boost search for HIV vaccine
Jan 19, 2018 2:57pm
